Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma

Overview of attention for article published in Clinical, Cosmetic and Investigational Dermatology, October 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

twitter: 1 X user

patent: 16 patents

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 45 Mendeley

So far, Altmetric has seen 16 patents that reference this research output.

Dove Medical Press

Article Metrics

Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma

About this Attention Score

Mentioned by

Citations

Readers on

Use of inhibitors of Brutons tyrosine kinase (Btk)

Grant US-11672803-B2

United States of America

Combination therapy using T cell redirection antigen binding molecule against cell having…

Grant US-11660340-B2

United States of America

Method for enhancing humoral immune response

Grant US-11649293-B2

United States of America

T cell-redirected antigen-binding molecule for cells having immunosuppression function

Grant US-11505605-B2

United States of America

Immunoactivating antigen-binding molecule

Grant US-11485790-B2

United States of America

Cytotoxicity-inducing therapeutic agent

Grant US-11066483-B2

United States of America

Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK)

Grant US-10954567-B2

United States of America

Use of inhibitors of Bruton's tyrosine kinase (Btk)

Grant US-10751342-B2

United States of America

Use of inhibitors of bruton's tyrosine kinase (BTK)

Grant US-10653696-B2

United States of America

Use of inhibitors of bruton's tyrosine kinase (Btk)

Grant US-10478439-B2

United States of America

Use of inhibitors of Bruton's tyrosine kinase (Btk)

Grant US-10016435-B2

United States of America

Use of inhibitors of Bruton'S tyrosine kinase (Btk)

Grant US-10004745-B2

United States of America

Use of inhibitors of Bruton's tyrosine kinase (Btk)

Grant US-10004746-B2

United States of America

Phospholipase C gamma 2 and resistance associated mutations

Grant US-9885086-B2

United States of America

Use of inhibitors of bruton'S tyrosine kinase (BTK)

Grant US-9814721-B2

United States of America

T CELL-REDIRECTED ANTIGEN-BINDING MOLECULE FOR CELLS HAVING IMMUNOSUPPRESSION FUNCTION

Application KR-20170017916-A

Republic of Korea